Cellectis (CLLS) Share-based Compensation (2015 - 2026)

Cellectis' Share-based Compensation history runs 12 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 70.39% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $6.8 million (up 108.75% YoY), while the FY2025 annual figure was $6.1 million, up 92.93% from the prior year.
• Share-based Compensation for Q1 2026 stood at $1.7 million, down from $2.2 million in the prior quarter.
• The five-year high for Share-based Compensation was $4.6 million in Q4 2023, with the low at -$2.7 million in Q3 2023.
• The 5-year median for Share-based Compensation is $1.3 million (2022), against an average of $1.3 million.
• The sharpest annual moves came in 2022 and 2023: Share-based Compensation jumped 7620.0% in 2022, then plunged 299.62% in 2023.
• Cellectis' Share-based Compensation stood at $387000.0 in 2022, then soared by 1094.06% to $4.6 million in 2023, then tumbled by 80.87% to $884000.0 in 2024, then jumped by 154.52% to $2.2 million in 2025, then fell by 26.09% to $1.7 million in 2026.
• Business Quant data shows CLLS's Share-based Compensation at $1.7 million in Q1 2026, $2.2 million in Q4 2025, and $1.6 million in Q3 2025.